Acceptability of Palliative Care in Parkinson Disease Care
Palliate-PD
Pilot to Assess the Acceptance of Palliative Care Referral Among Those With Parkinson Disease
1 other identifier
interventional
20
1 country
1
Brief Summary
This study will assess the feasibility of using specific criteria to standardize the referral of individuals with Parkinson disease to a group of medical providers known as palliative care specialists. Palliative care specialists provide supportive care to individuals living with serious illnesses. The specialty focuses on providing relief from the symptoms and stress of serious illness.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable parkinson-disease
Started Nov 2018
Shorter than P25 for not_applicable parkinson-disease
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 3, 2018
CompletedFirst Posted
Study publicly available on registry
October 5, 2018
CompletedStudy Start
First participant enrolled
November 16, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
June 2, 2019
CompletedDecember 9, 2019
December 1, 2019
7 months
October 3, 2018
December 5, 2019
Conditions
Outcome Measures
Primary Outcomes (1)
Proportion of enrolled participants who have at least 1 visit with a palliative care provider within 3 months of referral
We will assess the feasibility of standardized referral to palliative care by calculating the proportion of enrolled participants with Parkinson disease who have at least 1 visit with a palliative care provider within 3 months of referral.
3 months
Secondary Outcomes (6)
Change in mean symptom burden
Baseline to 3 months
Change in mean quality of life as assessed by the Quality of Life-Alzheimer Disease questionnaire (QoL-AD)
Baseline to 3 months
Change in mean caregiver burden
Baseline to 3 months
Change in mean caregiver self-efficacy
Baseline to 3 months
Barriers to palliative care referral
Baseline
- +1 more secondary outcomes
Study Arms (1)
Palliative Care referral
EXPERIMENTALParticipants with specific uncontrolled symptoms or critical events in course of their Parkinson disease will be referred to a palliative care specialist for supportive care.
Interventions
Individuals with Parkinson disease identified as having specific uncontrolled symptoms or critical events will undergo standardized referral to palliative care, who will provide supportive care. During the palliative care referral, participants and their care partners may discuss symptoms, disease burden (physical, emotion, financial, and psychological), quality of life, goals of care, and advance directive completion. Palliative care specialists may recommend interventions to manage bothersome symptoms or to improve disease burden for both participants and care partners.
Eligibility Criteria
You may qualify if:
- Diagnosis of idiopathic PD confirmed as most likely diagnosis with participant's treating provider
- years of age or older
- Participant or care partner able to provide informed consent
- Presence of one or more of the following:
- Uncontrolled symptoms (over prior week):
- Depression
- Pain
- Fatigue
- Critical events (over prior 6 months):
- ≥3 falls
- Unintended weight loss
- Wheelchair dependence (\>50% of time)
You may not qualify if:
- Diagnosis of atypical or secondary parkinsonism
- Outpatient palliative care visit scheduled or within the prior 6 months of the screening visit
- Subjects who are care partners:
- Care partner of enrolled participant in the study
- years of age or older
- Able to provide informed consent
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Rochesterlead
- American Academy of Neurologycollaborator
Study Sites (1)
URMC Neurology; 919 Westfall Rd, Building C
Rochester, New York, 14618, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Professor
Study Record Dates
First Submitted
October 3, 2018
First Posted
October 5, 2018
Study Start
November 16, 2018
Primary Completion
June 1, 2019
Study Completion
June 2, 2019
Last Updated
December 9, 2019
Record last verified: 2019-12
Data Sharing
- IPD Sharing
- Will not share